Baseline Health Check
Comprehensive blood test covering 70+ biomarkers with optimal ranges and biological age
Service · HybridCompany source
Company profile
About Vively
Vively is an Australian preventative healthcare company that helps individuals test, understand, and improve their health through comprehensive biomarker analysis and continuous monitoring. The company offers a Baseline Health Check covering 70+ health markers including metabolic health, cardiovascular risk, liver and kidney function, immune markers, thyroid, nutrient levels, inflammation, and biological age. Unlike standard blood tests that flag disease, Vively compares results against optimal ranges associated with long-term health and wellbeing. Founded to make preventative healthcare continuous rather than episodic, Vively addresses the gap in traditional healthcare which is built for sick care with short appointments and one-off tests. The platform combines advanced testing with registered health professional reviews, personalised action plans, and ongoing support from dietitians and nurses. Members can retest every 3-6 months to track progress and adjust their plans based on changing results. Vively also offers a CGM (Continuous Glucose Monitor) program that provides real-time data on how the body responds to food, sleep, and movement, with dietitian support to optimise metabolic health. The company serves over 30,000 Australian members through a subscription model starting at $99, with blood tests bulk-billed to Medicare. Vively's approach targets preventable chronic diseases by catching health risks years earlier through comprehensive biomarker tracking, body composition analysis, and lifestyle data integration.
Company description Vively official website
Primary marketMetabolic Health & Nutrition
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Vively?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Cardiovascular risk
- Chronic fatigue
- Inflammation
- Insulin resistance
- Metabolic health disorders
- PCOS
- Perimenopause
- Preventable chronic diseases
- Weight management
Who it serves
- Health-conscious Australians
- Individual consumers
- Men seeking energy optimization
- People with metabolic conditions
- Women with PCOS/perimenopause
Deployment & integration
Hybrid deployment with recorded integration context.
Recorded integration context: Accredited Australian pathology labs, Cycle tracking, Food tracking systems, Medicare bulk-billing, Wearables.
Geographic context
MarketsAustralia
Company sourceOfficial website
Company milestones
Platform expansion
Raised $1.6 million in funding (2023); Acquired Honee wellness booking platform (valued at 2x revenue); Partnered with Bupa; Reached 30,000+ members; Expanded to 4,000+ testing locations across Australia
Partnerships
Recorded partners
- Archangel Ventures
- Blackbird (via Honee acquisition)
- Bupa (investment and partnership)
- CommBank SmallBiz Week
- Salesforce
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
CGM Program
Real-time glucose monitoring for health and nutrition optimization
Device · HybridCompany source
Energy & Fatigue Investigation
Root-cause testing for persistent fatigue and energy issues
Service · HybridCompany source
Weight Management Test
Test for metabolic patterns linked to weight regulation and weight loss
Service · HybridCompany source
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
No linked records are currently available.
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
95% of members discover at least one marker outside normal range
Previously unknown health markers identified
84% of members have inflammation flagged
Including people who consider themselves healthy
86% made positive changes
Diet and lifestyle improvements after receiving results
Fasting insulin improvement 17 → 9 mIU/L
Over 3 months with program
Time in optimal glucose range 87%
CGM program participants
Jean (age 41)
Stubborn weight gain with unclear cause
Identified metabolic patterns linked to weight regulation through comprehensive testing
Member with inflammation
High hs-CRP inflammation marker
Reduced hs-CRP from 5 (High) to 0.8 (Optimal) over 4 retests through guided interventions
Member with insulin resistance
Elevated fasting insulin levels
Improved fasting insulin from 17 mIU/L to 9 mIU/L over 3 months
Sarah (age 37)
Energy crashes and fatigue after lunch despite eating well
Stopped feeling heavy crash after lunch with steady energy all day after making changes based on glucose monitoring
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Vively
Recent articles published on Vively's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Metabolic Health & Nutrition
Companies using AI to optimize metabolic health, provide personalized nutrition recommendations, or analyze metabolic responses to food for generally healthy or non-diabetic populations. Emphasizes wellness, performance optimization, and preventive health rather than management of a diagnosed disease.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.